Loading clinical trials...
Loading clinical trials...
Concentrations of Urinary Claudin-2, Caveolin-1, and Epidermal Growth Factor (EGF) as the Prototypes of Non-Invasive Biomarkers in the Diagnosis of Necrotizing Enterocolitis in Preterm Neonates
Conditions
Interventions
Urinary Claudin-2
Urinary Caveolin-1
+1 more
Locations
1
Indonesia
Saiful Anwar General Hospital
Malang, East Java, Indonesia
Start Date
March 17, 2022
Primary Completion Date
May 1, 2022
Completion Date
July 1, 2022
Last Updated
April 19, 2022
NCT07216664
NCT06335524
NCT07295106
NCT06878742
NCT06726226
NCT05030337
Lead Sponsor
University of Brawijaya
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions